Catalyst Pharmaceuticals Jobs & Careers
- Founded
- 2002
- Employees
- 75
- Total Funding
- $273.9M
Founded by Hubert E. Huckel, Patrick J McEnany in 2002.
About Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases. With exceptional patient focus, Catalyst is committed to developing a robust pipeline of cutting-edge, first- or best-in-class medicines for other rare diseases. Catalyst's New Drug Application for FIRDAPSE® (amifampridine) Tablets 10 mg for the treatment of adults with Lambert-Eaton myasthenic syndrome ("LEMS") was approved in 2018 by the U.S. Food & Drug Administration ("FDA"), and FIRDAPSE is commercially available in the United States as a treatment for adults with LEMS. Further, Canada's national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.
Leadership at Catalyst Pharmaceuticals
The team at the top of the org chart.
Patrick J. McEnany
Co-Founder, Chairman, President & CEO
124 reports
Gary Ingenito
Chief Medical and Regulatory Officer
30 reports
Alicia Grande
Vice President, Chief Financial Officer and Treasurer
9 reports
Brian Elsbernd
Chief Legal and Compliance Officer
1 report
Jeff Del Carmen
Chief Commercial Officer
54 reports
Steven R. Miller
Chief Operating Officer and Chief Scientific Officer
5 reports
Preethi Sundaram
Chief Business Officer
3 reports
Michael Kalb
EVP & Chief Financial Officer
7 reports
Will Andrews
Chief Medical Officer
9 reports
Board
Charles B. O’Keeffe
Lead Independent Director
David S. Tierney
Board Member
Richard J. Daly
Board Member
Molly Harper
Board Member
Donald A. Denkhaus
Board Member
Tamar Thompson
Board Member
Open Jobs at Catalyst Pharmaceuticals (5)
Similar companies hiring
Top employers in Health Care